nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP1A2—Anastrozole—breast cancer	0.0737	0.128	CbGbCtD
Secobarbital—CYP1A2—Toremifene—breast cancer	0.0674	0.117	CbGbCtD
Secobarbital—CYP2C9—Anastrozole—breast cancer	0.0664	0.115	CbGbCtD
Secobarbital—CYP2C8—Lapatinib—breast cancer	0.0635	0.11	CbGbCtD
Secobarbital—CYP2C9—Idarubicin—breast cancer	0.0503	0.0874	CbGbCtD
Secobarbital—CYP2C8—Raloxifene—breast cancer	0.0481	0.0836	CbGbCtD
Secobarbital—CYP2C8—Tamoxifen—breast cancer	0.0318	0.0553	CbGbCtD
Secobarbital—CYP2C9—Capecitabine—breast cancer	0.0276	0.0479	CbGbCtD
Secobarbital—CYP2C8—Paclitaxel—breast cancer	0.0248	0.043	CbGbCtD
Secobarbital—CYP1A2—Tamoxifen—breast cancer	0.0246	0.0428	CbGbCtD
Secobarbital—CHRFAM7A—corpus luteum—breast cancer	0.0242	0.304	CbGeAlD
Secobarbital—CYP2C8—Fluorouracil—breast cancer	0.0234	0.0407	CbGbCtD
Secobarbital—CYP2C9—Tamoxifen—breast cancer	0.0222	0.0385	CbGbCtD
Secobarbital—CHRNA7—corpus luteum—breast cancer	0.0196	0.245	CbGeAlD
Secobarbital—CYP1A2—Fluorouracil—breast cancer	0.0181	0.0315	CbGbCtD
Secobarbital—CYP2C9—Paclitaxel—breast cancer	0.0173	0.03	CbGbCtD
Secobarbital—CYP2C9—Fluorouracil—breast cancer	0.0163	0.0284	CbGbCtD
Secobarbital—GRIA2—embryo—breast cancer	0.00281	0.0352	CbGeAlD
Secobarbital—CYP2C8—mammary gland—breast cancer	0.0017	0.0213	CbGeAlD
Secobarbital—CHRNA7—skin of body—breast cancer	0.00161	0.0201	CbGeAlD
Secobarbital—GABRA4—pituitary gland—breast cancer	0.00158	0.0198	CbGeAlD
Secobarbital—CHRFAM7A—female reproductive system—breast cancer	0.00155	0.0195	CbGeAlD
Secobarbital—CYP2C9—mammary gland—breast cancer	0.00151	0.0189	CbGeAlD
Secobarbital—GRIA2—endocrine gland—breast cancer	0.00144	0.0181	CbGeAlD
Secobarbital—CHRFAM7A—female gonad—breast cancer	0.00141	0.0177	CbGeAlD
Secobarbital—CHRNA7—uterus—breast cancer	0.0014	0.0175	CbGeAlD
Secobarbital—GABRG2—pituitary gland—breast cancer	0.00132	0.0166	CbGeAlD
Secobarbital—CYP1A2—nipple—breast cancer	0.00132	0.0165	CbGeAlD
Secobarbital—CHRFAM7A—endocrine gland—breast cancer	0.00131	0.0165	CbGeAlD
Secobarbital—GRIK2—endocrine gland—breast cancer	0.0013	0.0163	CbGeAlD
Secobarbital—GABRA3—endocrine gland—breast cancer	0.00126	0.0158	CbGeAlD
Secobarbital—CHRNA7—female reproductive system—breast cancer	0.00125	0.0157	CbGeAlD
Secobarbital—CHRNA7—adrenal gland—breast cancer	0.00122	0.0153	CbGeAlD
Secobarbital—CHRNA4—adrenal gland—breast cancer	0.00121	0.0151	CbGeAlD
Secobarbital—GABRA2—adipose tissue—breast cancer	0.00121	0.0151	CbGeAlD
Secobarbital—CHRNA7—female gonad—breast cancer	0.00114	0.0143	CbGeAlD
Secobarbital—GABRA2—adrenal gland—breast cancer	0.00108	0.0135	CbGeAlD
Secobarbital—CHRNA7—endocrine gland—breast cancer	0.00106	0.0133	CbGeAlD
Secobarbital—CHRNA4—endocrine gland—breast cancer	0.00105	0.0131	CbGeAlD
Secobarbital—CYP2C8—endometrium—breast cancer	0.00085	0.0106	CbGeAlD
Secobarbital—CYP2C8—pituitary gland—breast cancer	0.000769	0.00963	CbGeAlD
Secobarbital—CYP2C8—female reproductive system—breast cancer	0.000704	0.00881	CbGeAlD
Secobarbital—GABRA2—lymph node—breast cancer	0.000648	0.00812	CbGeAlD
Secobarbital—CYP2C9—female reproductive system—breast cancer	0.000625	0.00783	CbGeAlD
Secobarbital—CYP2C8—endocrine gland—breast cancer	0.000596	0.00746	CbGeAlD
Secobarbital—Phenobarbital—ABCC1—breast cancer	0.000564	0.291	CrCbGaD
Secobarbital—CYP1A2—endocrine gland—breast cancer	0.000557	0.00698	CbGeAlD
Secobarbital—Agitation—Thiotepa—breast cancer	0.00054	0.00252	CcSEcCtD
Secobarbital—Dizziness—Raloxifene—breast cancer	0.000538	0.00251	CcSEcCtD
Secobarbital—Injection site reaction—Epirubicin—breast cancer	0.000538	0.00251	CcSEcCtD
Secobarbital—Headache—Letrozole—breast cancer	0.000537	0.00251	CcSEcCtD
Secobarbital—Headache—Anastrozole—breast cancer	0.000537	0.00251	CcSEcCtD
Secobarbital—Hypotension—Melphalan—breast cancer	0.000537	0.00251	CcSEcCtD
Secobarbital—Ataxia—Capecitabine—breast cancer	0.00053	0.00247	CcSEcCtD
Secobarbital—CYP2C9—endocrine gland—breast cancer	0.000529	0.00663	CbGeAlD
Secobarbital—Hypotension—Goserelin—breast cancer	0.000524	0.00244	CcSEcCtD
Secobarbital—Body temperature increased—Chlorambucil—breast cancer	0.000521	0.00243	CcSEcCtD
Secobarbital—Vomiting—Raloxifene—breast cancer	0.000517	0.00241	CcSEcCtD
Secobarbital—Vomiting—Idarubicin—breast cancer	0.000517	0.00241	CcSEcCtD
Secobarbital—Constipation—Vinblastine—breast cancer	0.000516	0.00241	CcSEcCtD
Secobarbital—Rash—Idarubicin—breast cancer	0.000513	0.00239	CcSEcCtD
Secobarbital—Rash—Raloxifene—breast cancer	0.000513	0.00239	CcSEcCtD
Secobarbital—Dermatitis—Idarubicin—breast cancer	0.000512	0.00239	CcSEcCtD
Secobarbital—Dermatitis—Raloxifene—breast cancer	0.000512	0.00239	CcSEcCtD
Secobarbital—Headache—Idarubicin—breast cancer	0.00051	0.00238	CcSEcCtD
Secobarbital—Headache—Raloxifene—breast cancer	0.00051	0.00238	CcSEcCtD
Secobarbital—Nausea—Letrozole—breast cancer	0.000509	0.00238	CcSEcCtD
Secobarbital—Nausea—Anastrozole—breast cancer	0.000509	0.00238	CcSEcCtD
Secobarbital—Constipation—Tamoxifen—breast cancer	0.000502	0.00234	CcSEcCtD
Secobarbital—Hepatocellular injury—Doxorubicin—breast cancer	0.0005	0.00234	CcSEcCtD
Secobarbital—Anxiety—Thiotepa—breast cancer	0.000498	0.00233	CcSEcCtD
Secobarbital—Somnolence—Goserelin—breast cancer	0.000498	0.00232	CcSEcCtD
Secobarbital—Feeling abnormal—Vinblastine—breast cancer	0.000498	0.00232	CcSEcCtD
Secobarbital—Injection site reaction—Doxorubicin—breast cancer	0.000497	0.00232	CcSEcCtD
Secobarbital—Hypersensitivity—Chlorambucil—breast cancer	0.000485	0.00227	CcSEcCtD
Secobarbital—Bradycardia—Paclitaxel—breast cancer	0.000484	0.00226	CcSEcCtD
Secobarbital—Nausea—Idarubicin—breast cancer	0.000483	0.00226	CcSEcCtD
Secobarbital—Nausea—Raloxifene—breast cancer	0.000483	0.00226	CcSEcCtD
Secobarbital—Confusional state—Thiotepa—breast cancer	0.000483	0.00226	CcSEcCtD
Secobarbital—Constipation—Goserelin—breast cancer	0.000479	0.00224	CcSEcCtD
Secobarbital—Mental disability—Epirubicin—breast cancer	0.000469	0.00219	CcSEcCtD
Secobarbital—Hypotension—Vinorelbine—breast cancer	0.000469	0.00219	CcSEcCtD
Secobarbital—Feeling abnormal—Goserelin—breast cancer	0.000462	0.00216	CcSEcCtD
Secobarbital—Syncope—Irinotecan—breast cancer	0.000455	0.00212	CcSEcCtD
Secobarbital—Loss of consciousness—Irinotecan—breast cancer	0.000446	0.00208	CcSEcCtD
Secobarbital—Hypersensitivity—Vinblastine—breast cancer	0.000445	0.00208	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Methotrexate—breast cancer	0.000445	0.00208	CcSEcCtD
Secobarbital—Body temperature increased—Goserelin—breast cancer	0.000443	0.00207	CcSEcCtD
Secobarbital—Mental disability—Doxorubicin—breast cancer	0.000434	0.00203	CcSEcCtD
Secobarbital—Hypersensitivity—Tamoxifen—breast cancer	0.000432	0.00202	CcSEcCtD
Secobarbital—Phenobarbital—CYP1B1—breast cancer	0.000431	0.223	CrCbGaD
Secobarbital—Anxiety—Mitoxantrone—breast cancer	0.00043	0.00201	CcSEcCtD
Secobarbital—Constipation—Vinorelbine—breast cancer	0.000429	0.002	CcSEcCtD
Secobarbital—Somnolence—Thiotepa—breast cancer	0.000426	0.00199	CcSEcCtD
Secobarbital—Hypersensitivity—Melphalan—breast cancer	0.000423	0.00198	CcSEcCtD
Secobarbital—Vomiting—Chlorambucil—breast cancer	0.000419	0.00196	CcSEcCtD
Secobarbital—Confusional state—Irinotecan—breast cancer	0.000417	0.00195	CcSEcCtD
Secobarbital—Confusional state—Mitoxantrone—breast cancer	0.000417	0.00195	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Epirubicin—breast cancer	0.000416	0.00194	CcSEcCtD
Secobarbital—Feeling abnormal—Vinorelbine—breast cancer	0.000413	0.00193	CcSEcCtD
Secobarbital—Hypersensitivity—Goserelin—breast cancer	0.000413	0.00193	CcSEcCtD
Secobarbital—Constipation—Thiotepa—breast cancer	0.00041	0.00191	CcSEcCtD
Secobarbital—Shock—Irinotecan—breast cancer	0.000407	0.0019	CcSEcCtD
Secobarbital—Shock—Mitoxantrone—breast cancer	0.000407	0.0019	CcSEcCtD
Secobarbital—Tension—Paclitaxel—breast cancer	0.000406	0.00189	CcSEcCtD
Secobarbital—Nervousness—Paclitaxel—breast cancer	0.000402	0.00187	CcSEcCtD
Secobarbital—Confusional state—Fluorouracil—breast cancer	0.0004	0.00187	CcSEcCtD
Secobarbital—Dizziness—Vinblastine—breast cancer	0.000399	0.00186	CcSEcCtD
Secobarbital—Bradycardia—Capecitabine—breast cancer	0.000397	0.00185	CcSEcCtD
Secobarbital—Body temperature increased—Vinorelbine—breast cancer	0.000397	0.00185	CcSEcCtD
Secobarbital—Feeling abnormal—Thiotepa—breast cancer	0.000395	0.00184	CcSEcCtD
Secobarbital—Ataxia—Methotrexate—breast cancer	0.000394	0.00184	CcSEcCtD
Secobarbital—Nausea—Chlorambucil—breast cancer	0.000391	0.00183	CcSEcCtD
Secobarbital—Dizziness—Tamoxifen—breast cancer	0.000388	0.00181	CcSEcCtD
Secobarbital—Hypotension—Mitoxantrone—breast cancer	0.000387	0.00181	CcSEcCtD
Secobarbital—Hypotension—Irinotecan—breast cancer	0.000387	0.00181	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Doxorubicin—breast cancer	0.000385	0.0018	CcSEcCtD
Secobarbital—Vomiting—Vinblastine—breast cancer	0.000384	0.00179	CcSEcCtD
Secobarbital—Agitation—Paclitaxel—breast cancer	0.00038	0.00177	CcSEcCtD
Secobarbital—Body temperature increased—Thiotepa—breast cancer	0.000379	0.00177	CcSEcCtD
Secobarbital—Headache—Vinblastine—breast cancer	0.000378	0.00177	CcSEcCtD
Secobarbital—Angioedema—Paclitaxel—breast cancer	0.000378	0.00176	CcSEcCtD
Secobarbital—Hypotension—Gemcitabine—breast cancer	0.000377	0.00176	CcSEcCtD
Secobarbital—Vomiting—Tamoxifen—breast cancer	0.000373	0.00174	CcSEcCtD
Secobarbital—Syncope—Paclitaxel—breast cancer	0.000371	0.00173	CcSEcCtD
Secobarbital—Dizziness—Goserelin—breast cancer	0.00037	0.00173	CcSEcCtD
Secobarbital—Hypotension—Fluorouracil—breast cancer	0.00037	0.00173	CcSEcCtD
Secobarbital—Rash—Tamoxifen—breast cancer	0.00037	0.00173	CcSEcCtD
Secobarbital—Hypersensitivity—Vinorelbine—breast cancer	0.00037	0.00173	CcSEcCtD
Secobarbital—Dermatitis—Tamoxifen—breast cancer	0.00037	0.00172	CcSEcCtD
Secobarbital—Ataxia—Epirubicin—breast cancer	0.000369	0.00172	CcSEcCtD
Secobarbital—Somnolence—Mitoxantrone—breast cancer	0.000368	0.00172	CcSEcCtD
Secobarbital—Somnolence—Irinotecan—breast cancer	0.000368	0.00172	CcSEcCtD
Secobarbital—Headache—Tamoxifen—breast cancer	0.000367	0.00172	CcSEcCtD
Secobarbital—Vomiting—Melphalan—breast cancer	0.000365	0.0017	CcSEcCtD
Secobarbital—Loss of consciousness—Paclitaxel—breast cancer	0.000363	0.0017	CcSEcCtD
Secobarbital—Rash—Melphalan—breast cancer	0.000362	0.00169	CcSEcCtD
Secobarbital—Dermatitis—Melphalan—breast cancer	0.000362	0.00169	CcSEcCtD
Secobarbital—Nausea—Vinblastine—breast cancer	0.000359	0.00167	CcSEcCtD
Secobarbital—Somnolence—Gemcitabine—breast cancer	0.000358	0.00167	CcSEcCtD
Secobarbital—Vomiting—Goserelin—breast cancer	0.000356	0.00166	CcSEcCtD
Secobarbital—Constipation—Irinotecan—breast cancer	0.000354	0.00165	CcSEcCtD
Secobarbital—Constipation—Mitoxantrone—breast cancer	0.000354	0.00165	CcSEcCtD
Secobarbital—Rash—Goserelin—breast cancer	0.000353	0.00165	CcSEcCtD
Secobarbital—Hypersensitivity—Thiotepa—breast cancer	0.000353	0.00165	CcSEcCtD
Secobarbital—Dermatitis—Goserelin—breast cancer	0.000353	0.00165	CcSEcCtD
Secobarbital—Somnolence—Fluorouracil—breast cancer	0.000352	0.00164	CcSEcCtD
Secobarbital—Headache—Goserelin—breast cancer	0.000351	0.00164	CcSEcCtD
Secobarbital—Anxiety—Paclitaxel—breast cancer	0.000351	0.00164	CcSEcCtD
Secobarbital—Nausea—Tamoxifen—breast cancer	0.000348	0.00163	CcSEcCtD
Secobarbital—Constipation—Gemcitabine—breast cancer	0.000345	0.00161	CcSEcCtD
Secobarbital—Ataxia—Doxorubicin—breast cancer	0.000342	0.00159	CcSEcCtD
Secobarbital—Nausea—Melphalan—breast cancer	0.000341	0.00159	CcSEcCtD
Secobarbital—Feeling abnormal—Mitoxantrone—breast cancer	0.000341	0.00159	CcSEcCtD
Secobarbital—Feeling abnormal—Irinotecan—breast cancer	0.000341	0.00159	CcSEcCtD
Secobarbital—Confusional state—Paclitaxel—breast cancer	0.00034	0.00159	CcSEcCtD
Secobarbital—Nausea—Goserelin—breast cancer	0.000333	0.00155	CcSEcCtD
Secobarbital—Feeling abnormal—Gemcitabine—breast cancer	0.000332	0.00155	CcSEcCtD
Secobarbital—Shock—Paclitaxel—breast cancer	0.000332	0.00155	CcSEcCtD
Secobarbital—Dizziness—Vinorelbine—breast cancer	0.000332	0.00155	CcSEcCtD
Secobarbital—Body temperature increased—Mitoxantrone—breast cancer	0.000327	0.00153	CcSEcCtD
Secobarbital—Body temperature increased—Irinotecan—breast cancer	0.000327	0.00153	CcSEcCtD
Secobarbital—Feeling abnormal—Fluorouracil—breast cancer	0.000327	0.00152	CcSEcCtD
Secobarbital—Vomiting—Vinorelbine—breast cancer	0.000319	0.00149	CcSEcCtD
Secobarbital—Body temperature increased—Gemcitabine—breast cancer	0.000319	0.00149	CcSEcCtD
Secobarbital—Dizziness—Thiotepa—breast cancer	0.000317	0.00148	CcSEcCtD
Secobarbital—Rash—Vinorelbine—breast cancer	0.000316	0.00148	CcSEcCtD
Secobarbital—Dermatitis—Vinorelbine—breast cancer	0.000316	0.00148	CcSEcCtD
Secobarbital—Hypotension—Paclitaxel—breast cancer	0.000315	0.00147	CcSEcCtD
Secobarbital—Headache—Vinorelbine—breast cancer	0.000314	0.00147	CcSEcCtD
Secobarbital—Syncope—Docetaxel—breast cancer	0.000314	0.00147	CcSEcCtD
Secobarbital—Body temperature increased—Fluorouracil—breast cancer	0.000313	0.00146	CcSEcCtD
Secobarbital—Loss of consciousness—Docetaxel—breast cancer	0.000308	0.00144	CcSEcCtD
Secobarbital—Hypersensitivity—Irinotecan—breast cancer	0.000305	0.00142	CcSEcCtD
Secobarbital—Hypersensitivity—Mitoxantrone—breast cancer	0.000305	0.00142	CcSEcCtD
Secobarbital—Vomiting—Thiotepa—breast cancer	0.000305	0.00142	CcSEcCtD
Secobarbital—Syncope—Capecitabine—breast cancer	0.000304	0.00142	CcSEcCtD
Secobarbital—Rash—Thiotepa—breast cancer	0.000302	0.00141	CcSEcCtD
Secobarbital—Dermatitis—Thiotepa—breast cancer	0.000302	0.00141	CcSEcCtD
Secobarbital—Headache—Thiotepa—breast cancer	0.0003	0.0014	CcSEcCtD
Secobarbital—Somnolence—Paclitaxel—breast cancer	0.0003	0.0014	CcSEcCtD
Secobarbital—Loss of consciousness—Capecitabine—breast cancer	0.000298	0.00139	CcSEcCtD
Secobarbital—Nausea—Vinorelbine—breast cancer	0.000298	0.00139	CcSEcCtD
Secobarbital—Hypersensitivity—Fluorouracil—breast cancer	0.000292	0.00136	CcSEcCtD
Secobarbital—Constipation—Paclitaxel—breast cancer	0.000289	0.00135	CcSEcCtD
Secobarbital—Confusional state—Docetaxel—breast cancer	0.000288	0.00135	CcSEcCtD
Secobarbital—Anxiety—Capecitabine—breast cancer	0.000288	0.00134	CcSEcCtD
Secobarbital—Nausea—Thiotepa—breast cancer	0.000285	0.00133	CcSEcCtD
Secobarbital—Shock—Docetaxel—breast cancer	0.000281	0.00131	CcSEcCtD
Secobarbital—Confusional state—Capecitabine—breast cancer	0.000279	0.0013	CcSEcCtD
Secobarbital—Feeling abnormal—Paclitaxel—breast cancer	0.000278	0.0013	CcSEcCtD
Secobarbital—Bradycardia—Epirubicin—breast cancer	0.000276	0.00129	CcSEcCtD
Secobarbital—Dizziness—Irinotecan—breast cancer	0.000274	0.00128	CcSEcCtD
Secobarbital—Shock—Capecitabine—breast cancer	0.000272	0.00127	CcSEcCtD
Secobarbital—Hypotension—Docetaxel—breast cancer	0.000267	0.00125	CcSEcCtD
Secobarbital—Body temperature increased—Paclitaxel—breast cancer	0.000267	0.00125	CcSEcCtD
Secobarbital—Vomiting—Irinotecan—breast cancer	0.000263	0.00123	CcSEcCtD
Secobarbital—Vomiting—Mitoxantrone—breast cancer	0.000263	0.00123	CcSEcCtD
Secobarbital—Dizziness—Fluorouracil—breast cancer	0.000262	0.00122	CcSEcCtD
Secobarbital—Rash—Mitoxantrone—breast cancer	0.000261	0.00122	CcSEcCtD
Secobarbital—Rash—Irinotecan—breast cancer	0.000261	0.00122	CcSEcCtD
Secobarbital—Dermatitis—Irinotecan—breast cancer	0.000261	0.00122	CcSEcCtD
Secobarbital—Dermatitis—Mitoxantrone—breast cancer	0.000261	0.00122	CcSEcCtD
Secobarbital—Headache—Irinotecan—breast cancer	0.000259	0.00121	CcSEcCtD
Secobarbital—Headache—Mitoxantrone—breast cancer	0.000259	0.00121	CcSEcCtD
Secobarbital—Hypotension—Capecitabine—breast cancer	0.000259	0.00121	CcSEcCtD
Secobarbital—Vomiting—Gemcitabine—breast cancer	0.000256	0.0012	CcSEcCtD
Secobarbital—Bradycardia—Doxorubicin—breast cancer	0.000256	0.00119	CcSEcCtD
Secobarbital—Somnolence—Docetaxel—breast cancer	0.000254	0.00119	CcSEcCtD
Secobarbital—Rash—Gemcitabine—breast cancer	0.000254	0.00119	CcSEcCtD
Secobarbital—Dermatitis—Gemcitabine—breast cancer	0.000254	0.00119	CcSEcCtD
Secobarbital—Headache—Gemcitabine—breast cancer	0.000253	0.00118	CcSEcCtD
Secobarbital—Vomiting—Fluorouracil—breast cancer	0.000252	0.00118	CcSEcCtD
Secobarbital—Rash—Fluorouracil—breast cancer	0.00025	0.00117	CcSEcCtD
Secobarbital—Dermatitis—Fluorouracil—breast cancer	0.00025	0.00117	CcSEcCtD
Secobarbital—Hypersensitivity—Paclitaxel—breast cancer	0.000249	0.00116	CcSEcCtD
Secobarbital—Headache—Fluorouracil—breast cancer	0.000248	0.00116	CcSEcCtD
Secobarbital—Nausea—Mitoxantrone—breast cancer	0.000246	0.00115	CcSEcCtD
Secobarbital—Nausea—Irinotecan—breast cancer	0.000246	0.00115	CcSEcCtD
Secobarbital—Constipation—Docetaxel—breast cancer	0.000245	0.00114	CcSEcCtD
Secobarbital—Nausea—Gemcitabine—breast cancer	0.000239	0.00112	CcSEcCtD
Secobarbital—Thiopental—CYP3A4—breast cancer	0.000239	0.123	CrCbGaD
Secobarbital—Constipation—Capecitabine—breast cancer	0.000237	0.00111	CcSEcCtD
Secobarbital—Feeling abnormal—Docetaxel—breast cancer	0.000236	0.0011	CcSEcCtD
Secobarbital—Nausea—Fluorouracil—breast cancer	0.000235	0.0011	CcSEcCtD
Secobarbital—Phenobarbital—CYP1A1—breast cancer	0.000233	0.12	CrCbGaD
Secobarbital—Tension—Epirubicin—breast cancer	0.000232	0.00108	CcSEcCtD
Secobarbital—Nervousness—Epirubicin—breast cancer	0.00023	0.00107	CcSEcCtD
Secobarbital—Feeling abnormal—Capecitabine—breast cancer	0.000228	0.00107	CcSEcCtD
Secobarbital—Body temperature increased—Docetaxel—breast cancer	0.000226	0.00106	CcSEcCtD
Secobarbital—Dizziness—Paclitaxel—breast cancer	0.000223	0.00104	CcSEcCtD
Secobarbital—Body temperature increased—Capecitabine—breast cancer	0.000219	0.00102	CcSEcCtD
Secobarbital—Agitation—Epirubicin—breast cancer	0.000217	0.00101	CcSEcCtD
Secobarbital—Tension—Doxorubicin—breast cancer	0.000215	0.001	CcSEcCtD
Secobarbital—Vomiting—Paclitaxel—breast cancer	0.000215	0.001	CcSEcCtD
Secobarbital—Rash—Paclitaxel—breast cancer	0.000213	0.000993	CcSEcCtD
Secobarbital—Dermatitis—Paclitaxel—breast cancer	0.000213	0.000992	CcSEcCtD
Secobarbital—Nervousness—Doxorubicin—breast cancer	0.000212	0.000992	CcSEcCtD
Secobarbital—Syncope—Epirubicin—breast cancer	0.000212	0.00099	CcSEcCtD
Secobarbital—Headache—Paclitaxel—breast cancer	0.000211	0.000987	CcSEcCtD
Secobarbital—Hypersensitivity—Docetaxel—breast cancer	0.000211	0.000984	CcSEcCtD
Secobarbital—Confusional state—Methotrexate—breast cancer	0.000208	0.00097	CcSEcCtD
Secobarbital—Loss of consciousness—Epirubicin—breast cancer	0.000208	0.00097	CcSEcCtD
Secobarbital—Hypersensitivity—Capecitabine—breast cancer	0.000204	0.000953	CcSEcCtD
Secobarbital—Agitation—Doxorubicin—breast cancer	0.000201	0.000938	CcSEcCtD
Secobarbital—Anxiety—Epirubicin—breast cancer	0.000201	0.000936	CcSEcCtD
Secobarbital—Nausea—Paclitaxel—breast cancer	0.0002	0.000936	CcSEcCtD
Secobarbital—Pentobarbital—CYP3A4—breast cancer	0.000198	0.102	CrCbGaD
Secobarbital—Syncope—Doxorubicin—breast cancer	0.000196	0.000916	CcSEcCtD
Secobarbital—Confusional state—Epirubicin—breast cancer	0.000195	0.000908	CcSEcCtD
Secobarbital—Hypotension—Methotrexate—breast cancer	0.000193	0.000899	CcSEcCtD
Secobarbital—Loss of consciousness—Doxorubicin—breast cancer	0.000192	0.000898	CcSEcCtD
Secobarbital—Shock—Epirubicin—breast cancer	0.00019	0.000886	CcSEcCtD
Secobarbital—Dizziness—Docetaxel—breast cancer	0.000189	0.000883	CcSEcCtD
Secobarbital—Anxiety—Doxorubicin—breast cancer	0.000186	0.000866	CcSEcCtD
Secobarbital—Somnolence—Methotrexate—breast cancer	0.000183	0.000856	CcSEcCtD
Secobarbital—Dizziness—Capecitabine—breast cancer	0.000183	0.000855	CcSEcCtD
Secobarbital—Vomiting—Docetaxel—breast cancer	0.000182	0.000849	CcSEcCtD
Secobarbital—Rash—Docetaxel—breast cancer	0.00018	0.000842	CcSEcCtD
Secobarbital—Hypotension—Epirubicin—breast cancer	0.00018	0.000842	CcSEcCtD
Secobarbital—Dermatitis—Docetaxel—breast cancer	0.00018	0.000841	CcSEcCtD
Secobarbital—Confusional state—Doxorubicin—breast cancer	0.00018	0.00084	CcSEcCtD
Secobarbital—Headache—Docetaxel—breast cancer	0.000179	0.000837	CcSEcCtD
Secobarbital—Vomiting—Capecitabine—breast cancer	0.000176	0.000822	CcSEcCtD
Secobarbital—Shock—Doxorubicin—breast cancer	0.000176	0.00082	CcSEcCtD
Secobarbital—Rash—Capecitabine—breast cancer	0.000175	0.000815	CcSEcCtD
Secobarbital—Dermatitis—Capecitabine—breast cancer	0.000174	0.000814	CcSEcCtD
Secobarbital—Headache—Capecitabine—breast cancer	0.000174	0.00081	CcSEcCtD
Secobarbital—Somnolence—Epirubicin—breast cancer	0.000172	0.000801	CcSEcCtD
Secobarbital—Nausea—Docetaxel—breast cancer	0.00017	0.000793	CcSEcCtD
Secobarbital—Feeling abnormal—Methotrexate—breast cancer	0.00017	0.000793	CcSEcCtD
Secobarbital—Hypotension—Doxorubicin—breast cancer	0.000167	0.000779	CcSEcCtD
Secobarbital—Constipation—Epirubicin—breast cancer	0.000165	0.00077	CcSEcCtD
Secobarbital—Nausea—Capecitabine—breast cancer	0.000165	0.000768	CcSEcCtD
Secobarbital—Body temperature increased—Methotrexate—breast cancer	0.000163	0.000761	CcSEcCtD
Secobarbital—Feeling abnormal—Epirubicin—breast cancer	0.000159	0.000742	CcSEcCtD
Secobarbital—Somnolence—Doxorubicin—breast cancer	0.000159	0.000741	CcSEcCtD
Secobarbital—Constipation—Doxorubicin—breast cancer	0.000153	0.000713	CcSEcCtD
Secobarbital—Body temperature increased—Epirubicin—breast cancer	0.000153	0.000712	CcSEcCtD
Secobarbital—Hypersensitivity—Methotrexate—breast cancer	0.000152	0.000709	CcSEcCtD
Secobarbital—Phenobarbital—CYP3A4—breast cancer	0.000149	0.0767	CrCbGaD
Secobarbital—Feeling abnormal—Doxorubicin—breast cancer	0.000147	0.000687	CcSEcCtD
Secobarbital—Hypersensitivity—Epirubicin—breast cancer	0.000142	0.000664	CcSEcCtD
Secobarbital—Body temperature increased—Doxorubicin—breast cancer	0.000141	0.000659	CcSEcCtD
Secobarbital—Dizziness—Methotrexate—breast cancer	0.000136	0.000636	CcSEcCtD
Secobarbital—Hypersensitivity—Doxorubicin—breast cancer	0.000132	0.000614	CcSEcCtD
Secobarbital—Vomiting—Methotrexate—breast cancer	0.000131	0.000612	CcSEcCtD
Secobarbital—Rash—Methotrexate—breast cancer	0.00013	0.000607	CcSEcCtD
Secobarbital—Dermatitis—Methotrexate—breast cancer	0.00013	0.000606	CcSEcCtD
Secobarbital—Headache—Methotrexate—breast cancer	0.000129	0.000603	CcSEcCtD
Secobarbital—Dizziness—Epirubicin—breast cancer	0.000128	0.000596	CcSEcCtD
Secobarbital—Phenobarbital—ABCB1—breast cancer	0.000124	0.0639	CrCbGaD
Secobarbital—Vomiting—Epirubicin—breast cancer	0.000123	0.000573	CcSEcCtD
Secobarbital—Nausea—Methotrexate—breast cancer	0.000122	0.000572	CcSEcCtD
Secobarbital—Rash—Epirubicin—breast cancer	0.000122	0.000568	CcSEcCtD
Secobarbital—Dermatitis—Epirubicin—breast cancer	0.000122	0.000567	CcSEcCtD
Secobarbital—Headache—Epirubicin—breast cancer	0.000121	0.000564	CcSEcCtD
Secobarbital—Dizziness—Doxorubicin—breast cancer	0.000118	0.000551	CcSEcCtD
Secobarbital—Nausea—Epirubicin—breast cancer	0.000115	0.000535	CcSEcCtD
Secobarbital—Vomiting—Doxorubicin—breast cancer	0.000114	0.00053	CcSEcCtD
Secobarbital—Rash—Doxorubicin—breast cancer	0.000113	0.000525	CcSEcCtD
Secobarbital—Dermatitis—Doxorubicin—breast cancer	0.000112	0.000525	CcSEcCtD
Secobarbital—Headache—Doxorubicin—breast cancer	0.000112	0.000522	CcSEcCtD
Secobarbital—Nausea—Doxorubicin—breast cancer	0.000106	0.000495	CcSEcCtD
Secobarbital—CYP2C9—Metabolism—ALDH1A1—breast cancer	1.63e-05	0.000127	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	1.62e-05	0.000126	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.61e-05	0.000125	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.61e-05	0.000125	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.6e-05	0.000125	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.6e-05	0.000124	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.59e-05	0.000124	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA2—breast cancer	1.59e-05	0.000124	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GPX2—breast cancer	1.59e-05	0.000124	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GPX4—breast cancer	1.57e-05	0.000122	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SULT1A1—breast cancer	1.57e-05	0.000122	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ADSL—breast cancer	1.56e-05	0.000121	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NME1—breast cancer	1.56e-05	0.000121	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—FHL2—breast cancer	1.56e-05	0.000121	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PHGDH—breast cancer	1.56e-05	0.000121	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—UMPS—breast cancer	1.56e-05	0.000121	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ANGPTL4—breast cancer	1.54e-05	0.00012	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ESRRA—breast cancer	1.54e-05	0.00012	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—IDH1—breast cancer	1.53e-05	0.000119	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA1—breast cancer	1.53e-05	0.000119	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—LDHB—breast cancer	1.53e-05	0.000119	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HPSE—breast cancer	1.53e-05	0.000119	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—BRIP1—breast cancer	1.53e-05	0.000119	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NAT2—breast cancer	1.51e-05	0.000118	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.46e-05	0.000114	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GPI—breast cancer	1.46e-05	0.000114	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HADHB—breast cancer	1.46e-05	0.000114	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA3—breast cancer	1.45e-05	0.000113	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCC1—breast cancer	1.45e-05	0.000113	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HMMR—breast cancer	1.45e-05	0.000113	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PPARGC1B—breast cancer	1.4e-05	0.000109	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.39e-05	0.000109	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALDH1A1—breast cancer	1.39e-05	0.000108	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALDH7A1—breast cancer	1.39e-05	0.000108	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.37e-05	0.000107	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.37e-05	0.000107	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.37e-05	0.000106	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.37e-05	0.000106	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PHGDH—breast cancer	1.33e-05	0.000104	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ADSL—breast cancer	1.33e-05	0.000104	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—FHL2—breast cancer	1.33e-05	0.000104	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NME1—breast cancer	1.33e-05	0.000104	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—UMPS—breast cancer	1.33e-05	0.000104	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MED12—breast cancer	1.33e-05	0.000103	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—DPYD—breast cancer	1.33e-05	0.000103	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CA9—breast cancer	1.33e-05	0.000103	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA4—breast cancer	1.33e-05	0.000103	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.31e-05	0.000102	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALDOA—breast cancer	1.31e-05	0.000102	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—BRIP1—breast cancer	1.31e-05	0.000102	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HPSE—breast cancer	1.31e-05	0.000102	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—LDHB—breast cancer	1.31e-05	0.000102	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.3e-05	0.000101	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GPX2—breast cancer	1.29e-05	0.000101	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA2—breast cancer	1.29e-05	0.000101	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GPX4—breast cancer	1.28e-05	9.94e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SULT1A1—breast cancer	1.28e-05	9.94e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NCOA3—breast cancer	1.27e-05	9.89e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC2A2—breast cancer	1.26e-05	9.82e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.25e-05	9.72e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA1—breast cancer	1.25e-05	9.71e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—IDH1—breast cancer	1.25e-05	9.71e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCC1—breast cancer	1.24e-05	9.65e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HMMR—breast cancer	1.24e-05	9.65e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA3—breast cancer	1.24e-05	9.65e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CPT1A—breast cancer	1.23e-05	9.62e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCG2—breast cancer	1.23e-05	9.62e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MTR—breast cancer	1.23e-05	9.62e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NAT2—breast cancer	1.23e-05	9.6e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HPGDS—breast cancer	1.21e-05	9.43e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HBA1—breast cancer	1.2e-05	9.37e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PPARGC1B—breast cancer	1.2e-05	9.35e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTT1—breast cancer	1.17e-05	9.15e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ACHE—breast cancer	1.17e-05	9.15e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.17e-05	9.1e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.17e-05	9.1e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CA9—breast cancer	1.13e-05	8.83e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA4—breast cancer	1.13e-05	8.83e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.12e-05	8.72e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.11e-05	8.68e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP17A1—breast cancer	1.11e-05	8.66e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.11e-05	8.63e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GPX2—breast cancer	1.1e-05	8.6e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA2—breast cancer	1.1e-05	8.6e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTGS1—breast cancer	1.1e-05	8.57e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ENO1—breast cancer	1.1e-05	8.57e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.1e-05	8.54e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SULT1A1—breast cancer	1.09e-05	8.5e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GPX4—breast cancer	1.09e-05	8.5e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.08e-05	8.43e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MED12—breast cancer	1.08e-05	8.42e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—DPYD—breast cancer	1.08e-05	8.42e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2D6—breast cancer	1.08e-05	8.41e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—IDH1—breast cancer	1.06e-05	8.3e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA1—breast cancer	1.06e-05	8.3e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALDOA—breast cancer	1.06e-05	8.29e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NCOA2—breast cancer	1.06e-05	8.25e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NAT2—breast cancer	1.05e-05	8.21e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NCOA3—breast cancer	1.03e-05	8.05e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—FASN—breast cancer	1.03e-05	8e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC2A2—breast cancer	1.03e-05	7.99e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—BCHE—breast cancer	1.02e-05	7.97e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.01e-05	7.91e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC5A5—breast cancer	1.01e-05	7.87e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CPT1A—breast cancer	1e-05	7.83e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MTR—breast cancer	1e-05	7.83e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCG2—breast cancer	1e-05	7.83e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HPGDS—breast cancer	9.85e-06	7.68e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HBA1—breast cancer	9.79e-06	7.63e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC2A1—breast cancer	9.75e-06	7.6e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NQO1—breast cancer	9.75e-06	7.6e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTT1—breast cancer	9.55e-06	7.45e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ACHE—breast cancer	9.55e-06	7.45e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	9.55e-06	7.45e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.52e-06	7.42e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP3A4—breast cancer	9.51e-06	7.41e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	9.46e-06	7.38e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1B1—breast cancer	9.35e-06	7.29e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MED12—breast cancer	9.23e-06	7.2e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—DPYD—breast cancer	9.23e-06	7.2e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HSP90AA1—breast cancer	9.17e-06	7.15e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALDOA—breast cancer	9.09e-06	7.08e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP17A1—breast cancer	9.04e-06	7.05e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTGS1—breast cancer	8.95e-06	6.98e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ENO1—breast cancer	8.95e-06	6.98e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NCOA1—breast cancer	8.92e-06	6.95e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.92e-06	6.95e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NCOA3—breast cancer	8.82e-06	6.88e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.8e-06	6.86e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—STK11—breast cancer	8.79e-06	6.85e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP19A1—breast cancer	8.79e-06	6.85e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2D6—breast cancer	8.78e-06	6.84e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC2A2—breast cancer	8.76e-06	6.83e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.67e-06	6.76e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NCOA2—breast cancer	8.62e-06	6.72e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MTR—breast cancer	8.58e-06	6.69e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CPT1A—breast cancer	8.58e-06	6.69e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCG2—breast cancer	8.58e-06	6.69e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HPGDS—breast cancer	8.42e-06	6.56e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HBA1—breast cancer	8.36e-06	6.52e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—FASN—breast cancer	8.36e-06	6.51e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—BCHE—breast cancer	8.32e-06	6.49e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.25e-06	6.43e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC5A5—breast cancer	8.22e-06	6.41e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—COMT—breast cancer	8.17e-06	6.37e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTT1—breast cancer	8.16e-06	6.36e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ACHE—breast cancer	8.16e-06	6.36e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTP1—breast cancer	8.14e-06	6.34e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HMOX1—breast cancer	8.02e-06	6.25e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ITPR1—breast cancer	8e-06	6.24e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NQO1—breast cancer	7.94e-06	6.19e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC2A1—breast cancer	7.94e-06	6.19e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.77e-06	6.06e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP3A4—breast cancer	7.74e-06	6.03e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP17A1—breast cancer	7.73e-06	6.02e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.7e-06	6e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCB1—breast cancer	7.7e-06	6e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTGS1—breast cancer	7.65e-06	5.96e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ENO1—breast cancer	7.65e-06	5.96e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.62e-06	5.94e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1B1—breast cancer	7.61e-06	5.93e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TYMS—breast cancer	7.56e-06	5.9e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.52e-06	5.86e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2D6—breast cancer	7.5e-06	5.85e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PLA2G4A—breast cancer	7.48e-06	5.83e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTM1—breast cancer	7.48e-06	5.83e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NCOR1—breast cancer	7.48e-06	5.83e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HSP90AA1—breast cancer	7.46e-06	5.82e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NCOA2—breast cancer	7.36e-06	5.74e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NCOA1—breast cancer	7.26e-06	5.66e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GPX1—breast cancer	7.16e-06	5.58e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—STK11—breast cancer	7.16e-06	5.58e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP19A1—breast cancer	7.16e-06	5.58e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—FASN—breast cancer	7.14e-06	5.57e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—BCHE—breast cancer	7.11e-06	5.54e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1A1—breast cancer	7.09e-06	5.52e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ERCC2—breast cancer	7.03e-06	5.48e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC5A5—breast cancer	7.02e-06	5.48e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NQO1—breast cancer	6.78e-06	5.29e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC2A1—breast cancer	6.78e-06	5.29e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.72e-06	5.24e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—COMT—breast cancer	6.65e-06	5.19e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.64e-06	5.18e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTP1—breast cancer	6.62e-06	5.16e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP3A4—breast cancer	6.62e-06	5.16e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MTHFR—breast cancer	6.61e-06	5.15e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.58e-06	5.13e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HMOX1—breast cancer	6.53e-06	5.09e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ITPR1—breast cancer	6.51e-06	5.08e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP1B1—breast cancer	6.5e-06	5.07e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HSP90AA1—breast cancer	6.38e-06	4.97e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCB1—breast cancer	6.27e-06	4.89e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NCOA1—breast cancer	6.2e-06	4.84e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TYMS—breast cancer	6.16e-06	4.8e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—STK11—breast cancer	6.11e-06	4.77e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP19A1—breast cancer	6.11e-06	4.77e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CAV1—breast cancer	6.09e-06	4.75e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PLA2G4A—breast cancer	6.08e-06	4.74e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTM1—breast cancer	6.08e-06	4.74e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NCOR1—breast cancer	6.08e-06	4.74e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GPX1—breast cancer	5.83e-06	4.54e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.82e-06	4.54e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1A1—breast cancer	5.77e-06	4.5e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.74e-06	4.47e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ERCC2—breast cancer	5.72e-06	4.46e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—COMT—breast cancer	5.68e-06	4.43e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTP1—breast cancer	5.66e-06	4.41e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HMOX1—breast cancer	5.58e-06	4.35e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ITPR1—breast cancer	5.57e-06	4.34e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CG—breast cancer	5.55e-06	4.33e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MTHFR—breast cancer	5.38e-06	4.19e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCB1—breast cancer	5.36e-06	4.17e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TYMS—breast cancer	5.26e-06	4.1e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NCOR1—breast cancer	5.2e-06	4.05e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PLA2G4A—breast cancer	5.2e-06	4.05e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTM1—breast cancer	5.2e-06	4.05e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GPX1—breast cancer	4.98e-06	3.88e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CAV1—breast cancer	4.96e-06	3.87e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP1A1—breast cancer	4.93e-06	3.84e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ERCC2—breast cancer	4.89e-06	3.81e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CD—breast cancer	4.88e-06	3.8e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALB—breast cancer	4.82e-06	3.76e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.74e-06	3.69e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NOS3—breast cancer	4.61e-06	3.59e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MTHFR—breast cancer	4.59e-06	3.58e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CG—breast cancer	4.52e-06	3.52e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CB—breast cancer	4.25e-06	3.32e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CAV1—breast cancer	4.24e-06	3.3e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTGS2—breast cancer	4.21e-06	3.29e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.05e-06	3.16e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CD—breast cancer	3.97e-06	3.1e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALB—breast cancer	3.92e-06	3.06e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CG—breast cancer	3.86e-06	3.01e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NOS3—breast cancer	3.75e-06	2.92e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTEN—breast cancer	3.68e-06	2.87e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CB—breast cancer	3.46e-06	2.7e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTGS2—breast cancer	3.43e-06	2.67e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CD—breast cancer	3.39e-06	2.65e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALB—breast cancer	3.35e-06	2.61e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NOS3—breast cancer	3.2e-06	2.5e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTEN—breast cancer	2.99e-06	2.33e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CB—breast cancer	2.96e-06	2.31e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTGS2—breast cancer	2.93e-06	2.28e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CA—breast cancer	2.59e-06	2.02e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTEN—breast cancer	2.56e-06	1.99e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—AKT1—breast cancer	2.12e-06	1.65e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CA—breast cancer	2.11e-06	1.65e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CA—breast cancer	1.8e-06	1.41e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—AKT1—breast cancer	1.72e-06	1.34e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—AKT1—breast cancer	1.47e-06	1.15e-05	CbGpPWpGaD
